{"id":956,"date":"2018-07-31T22:11:48","date_gmt":"2018-07-31T22:11:48","guid":{"rendered":"https:\/\/stockchase.com\/discover\/?p=956"},"modified":"2022-12-01T13:15:15","modified_gmt":"2022-12-01T18:15:15","slug":"pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider","status":"publish","type":"post","link":"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/","title":{"rendered":"Pharma Index going Upwards \u2014 Top 3 Drug Manufacturers You Should Consider"},"content":{"rendered":"<p><img fetchpriority=\"high\" decoding=\"async\" title=\"pharma-3tops.jpg\" src=\"https:\/\/stockchase.com\/discover\/wp-content\/uploads\/2018\/07\/pharma-3tops.jpg\" alt=\"Pharma 3tops\" width=\"795\" height=\"464\" border=\"0\" \/>[adinserter block=&#8221;4&#8243;]<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Discover What&#039;s Inside<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/#2018_Volatile_year_for_drug_manufacturers\" >2018: Volatile year for drug manufacturers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/#Pharma_ETF_as_a_benchmark\" >Pharma ETF as a benchmark<\/a><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/#XPH-N\" >XPH-N<\/a><\/li><\/ul><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/#SPDR_Pharma_ETF\" >SPDR Pharma ETF<\/a><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/#JNJ-N\" >JNJ-N<\/a><\/li><\/ul><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/#Johnson_Johnson\" >Johnson &amp; Johnson<\/a><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/#MRK-N\" >MRK-N<\/a><\/li><\/ul><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/#Merck_Company\" >Merck &amp; Company<\/a><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><ul class='ez-toc-list-level-6' ><li class='ez-toc-heading-level-6'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/#PFE-N\" >PFE-N<\/a><\/li><\/ul><\/li><\/ul><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/#Pfizer_Inc\" >Pfizer Inc.<\/a><\/li><\/ul><\/nav><\/div>\n<h3><span class=\"ez-toc-section\" id=\"2018_Volatile_year_for_drug_manufacturers\"><\/span>2018: Volatile year for drug manufacturers<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>2018 remains the volatile year for the drug manufacturers.<\/p>\n<p>The recent steep rise in US Pharma companies has pushed the overall Pharma index upwards. Upon May 11, 2018 announcement of\u00a0<a href=\"https:\/\/www.whitehouse.gov\/briefings-statements\/president-donald-j-trumps-blueprint-lower-drug-prices\/\" target=\"_blank\" rel=\"noopener\">President Donald J. Trump\u2019s Blueprint To Lower Drug Prices<\/a>\u00a0 the pharmaceutical sector took a sigh of relief.\u00a0The major point which everyone was fearful of were not included in the statement.<\/p>\n<p>Trump administration&#8217;s intervention,\u00a0Competition from Generic and &#8220;Me-too&#8221; drugs were affecting the demands for Branded and Proprietary drugs.\u00a0Overall this sector remain subdued since beginning of the year up till recently.<\/p>\n<p>The proposal excluded the recommendations like &#8211;\u00a0allowing the government to negotiate drug prices directly with manufacturers or importing lower-cost prescription drugs from abroad,\u00a0and others.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Pharma_ETF_as_a_benchmark\"><\/span>Pharma ETF as a benchmark<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Looking at <a href=\"https:\/\/stockchase.com\/company\/view\/4613\">SPDR Pharma ETF (XPH-N)<\/a> could be a good benchmark. It has been up more than 10% since last three months.<\/p>\n<p>The fund seeks to invest in stocks of companies operating across the pharmaceuticals sector. It invests in stocks of companies across all market capitalizations, with a market capitalization above $500 Million.\u00a0US Pharma companies has increased the prices in recent periods. This applies to both branded and the old generics drugs.<\/p>\n<h6><span class=\"ez-toc-section\" id=\"XPH-N\"><\/span>XPH-N<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h3><span class=\"ez-toc-section\" id=\"SPDR_Pharma_ETF\"><\/span>SPDR Pharma ETF<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<!-- TradingView Widget BEGIN -->\r\n<div class=\"tradingview-widget-container\">\r\n  <div id=\"tradingview_1756aa\"><\/div>\r\n  <div class=\"tradingview-widget-copyright\"><a href=\"https:\/\/www.tradingview.com\/symbols\/AMEX-XPH\/\" rel=\"noopener\" target=\"_blank\"><span class=\"blue-text\">XPH chart<\/span><\/a> by TradingView<\/div>\r\n  <script type=\"text\/javascript\" src=\"https:\/\/s3.tradingview.com\/tv.js\"><\/script>\r\n  <script type=\"text\/javascript\">\r\n  new TradingView.widget(\r\n  {\r\n  \"autosize\": true,\r\n  \"symbol\": \"AMEX:XPH\",\r\n  \"interval\": \"D\",\r\n  \"timezone\": \"Etc\/UTC\",\r\n  \"theme\": \"Light\",\r\n  \"style\": \"3\",\r\n  \"locale\": \"en\",\r\n  \"toolbar_bg\": \"#f1f3f6\",\r\n  \"enable_publishing\": false,\r\n  \"hide_top_toolbar\": true,\r\n  \"allow_symbol_change\": true,\r\n  \"save_image\": false,\r\n  \"referral_id\": \"12055\",\r\n  \"container_id\": \"tradingview_1756aa\"\r\n}\r\n  );\r\n  <\/script>\r\n<\/div>\r\n<!-- TradingView Widget END -->\r\n\u00a0\n<p>Based on <a href=\"https:\/\/stockchase.com\/opinions\/recent\">Stockchase Expert Opinions<\/a> and Technical Analysis, we believe below three companies are good potential stocks for trend following strategy followers. All the three stocks are up more than 10% over last one month period and possesses the great potential to be looked at.<\/p>\n<p>Discover the 3 stocks on the <a href=\"https:\/\/stockchase.com\/discover\/pharma-index-going-upwards-top-3-drug-manufacturers-you-should-consider\/2\/\">next page<\/a>&#8230;<\/p>\n<p><em><a href=\"https:\/\/en.wikipedia.org\/wiki\/Trend_following\" target=\"_blank\" rel=\"noopener\">Trend Following<\/a>\u00a0is a trading strategy according to which one should buy an asset when its price trend goes up, and sell when its trend goes down, expecting price movements to continue.<\/em><\/p>\n<p>[nextpage title=&#8221;10 drugs, $1 billion potential&#8221;]<\/p>\n<h6><span class=\"ez-toc-section\" id=\"JNJ-N\"><\/span>JNJ-N<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h3><span class=\"ez-toc-section\" id=\"Johnson_Johnson\"><\/span>Johnson &amp; Johnson<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><img decoding=\"async\" title=\"johnson-johnson.png\" src=\"https:\/\/stockchase.com\/discover\/wp-content\/uploads\/2018\/07\/johnson-johnson.png\" alt=\"Johnson johnson\" width=\"793\" height=\"429\" border=\"0\" \/>[adinserter block=&#8221;4&#8243;]<\/p>\n<!-- TradingView Widget BEGIN -->\r\n<div class=\"tradingview-widget-container\">\r\n  <div id=\"tradingview_1756ab\"><\/div>\r\n  <div class=\"tradingview-widget-copyright\"><a href=\"https:\/\/www.tradingview.com\/symbols\/NYSE-JNJ\/\" rel=\"noopener\" target=\"_blank\"><span class=\"blue-text\">JNJ chart<\/span><\/a> by TradingView<\/div>\r\n  <script type=\"text\/javascript\" src=\"https:\/\/s3.tradingview.com\/tv.js\"><\/script>\r\n  <script type=\"text\/javascript\">\r\n  new TradingView.widget(\r\n  {\r\n  \"autosize\": true,\r\n  \"symbol\": \"NYSE:JNJ\",\r\n  \"interval\": \"D\",\r\n  \"timezone\": \"Etc\/UTC\",\r\n  \"theme\": \"Light\",\r\n  \"style\": \"3\",\r\n  \"locale\": \"en\",\r\n  \"toolbar_bg\": \"#f1f3f6\",\r\n  \"enable_publishing\": false,\r\n  \"hide_top_toolbar\": true,\r\n  \"allow_symbol_change\": true,\r\n  \"save_image\": false,\r\n  \"referral_id\": \"12055\",\r\n  \"container_id\": \"tradingview_1756ab\"\r\n}\r\n  );\r\n  <\/script>\r\n<\/div>\r\n<!-- TradingView Widget END -->\r\n\u00a0\n<p>Recent comments from stock experts Christine Poole and Gordon Reid suggest to buy this stock.<\/p>\n<div class=\"perfect-pullquote vcard pullquote-align-full pullquote-border-placement-left\"><blockquote cite=\"https:\/\/stockchase.com\/expert\/view\/1274\/Christine-Poole\"><p>Their stock has done nothing this year, partially because of pricing pressure from Donald Trump. She thinks their pharma division is doing well, with lots of new products and a good pipeline. They have identified 10 drugs that have a $1 billion potential. This company spends 13% of revenues on R&amp;D, which shows a serious level of investment in the future. They have also made some acquisitions to go into new areas. They have increased their dividend consistently for over 50 years.\u00a0<em>(Analysts\u2019 price target is $143.29)<\/em><\/p><footer itemscope itemtype=\"http:\/\/schema.org\/Person\"><cite><a href=\"https:\/\/stockchase.com\/expert\/view\/1274\/Christine-Poole\" class=\"url\" target=\"_blank\" itemprop=\"url\"><span itemprop=\"name\">Christine Poole<\/span><\/a><\/cite><\/footer><\/blockquote><\/div>\n<div class=\"perfect-pullquote vcard pullquote-align-full pullquote-border-placement-left\"><blockquote cite=\"https:\/\/stockchase.com\/expert\/view\/1204\/Gordon-Reid\"><p>It is a very well run company.\u00a0 Pharma, medical supply and personal goods businesses.\u00a0 The pharma business is doing well.\u00a0 They have a number of drugs.\u00a0 Brands are not as valued by millennials as by their predecessors.\u00a0 This is the struggle that JNJ-N is having.\u00a0 They have a strong balance sheet and a nice dividend.<\/p><footer itemscope itemtype=\"http:\/\/schema.org\/Person\"><cite><a href=\"https:\/\/stockchase.com\/expert\/view\/1204\/Gordon-Reid\" class=\"url\" target=\"_blank\" itemprop=\"url\"><span itemprop=\"name\">Gordon Reid<\/span><\/a><\/cite><\/footer><\/blockquote><\/div>\n<p>[nextpage title=&#8221;The market underestimates the growth potential of this stock&#8221;]<\/p>\n<h6><span class=\"ez-toc-section\" id=\"MRK-N\"><\/span>MRK-N<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h3><span class=\"ez-toc-section\" id=\"Merck_Company\"><\/span>Merck &amp; Company<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><img decoding=\"async\" title=\"merck-pharma.png\" src=\"https:\/\/stockchase.com\/discover\/wp-content\/uploads\/2018\/07\/merck-pharma.png\" alt=\"Merck pharma\" width=\"794\" height=\"466\" border=\"0\" \/> [adinserter block=&#8221;4&#8243;]<\/p>\n<!-- TradingView Widget BEGIN -->\r\n<div class=\"tradingview-widget-container\">\r\n  <div id=\"tradingview_1756ac\"><\/div>\r\n  <div class=\"tradingview-widget-copyright\"><a href=\"https:\/\/www.tradingview.com\/symbols\/NYSE-MRK\/\" rel=\"noopener\" target=\"_blank\"><span class=\"blue-text\">MRK chart<\/span><\/a> by TradingView<\/div>\r\n  <script type=\"text\/javascript\" src=\"https:\/\/s3.tradingview.com\/tv.js\"><\/script>\r\n  <script type=\"text\/javascript\">\r\n  new TradingView.widget(\r\n  {\r\n  \"autosize\": true,\r\n  \"symbol\": \"NYSE:MRK\",\r\n  \"interval\": \"D\",\r\n  \"timezone\": \"Etc\/UTC\",\r\n  \"theme\": \"Light\",\r\n  \"style\": \"3\",\r\n  \"locale\": \"en\",\r\n  \"toolbar_bg\": \"#f1f3f6\",\r\n  \"enable_publishing\": false,\r\n  \"hide_top_toolbar\": true,\r\n  \"allow_symbol_change\": true,\r\n  \"save_image\": false,\r\n  \"referral_id\": \"12055\",\r\n  \"container_id\": \"tradingview_1756ac\"\r\n}\r\n  );\r\n  <\/script>\r\n<\/div>\r\n<!-- TradingView Widget END -->\r\n\u00a0\n<p>Merck was recently selected as a Top Pick by stock experts Harp Sn and Paul Macdonald&#8230;<\/p>\n<div class=\"perfect-pullquote vcard pullquote-align-full pullquote-border-placement-left\"><blockquote><p>He started buying in December and thinks the market has beaten the stock up over the Trump Administration move to curb pharmaceutical pricing. He thinks the market is underestimating sales growth. The sector is in a secular bull market. Yield 3.1%.\u00a0<em>(Analysts\u2019 price target is $69.16)<\/em><\/p><footer itemscope itemtype=\"http:\/\/schema.org\/Person\"><cite><span itemprop=\"name\">Harp (Robert) Sn<\/span><\/cite><\/footer><\/blockquote><\/div>\n<div class=\"perfect-pullquote vcard pullquote-align-full pullquote-border-placement-left\"><blockquote><p><strong>(A Top Pick September 14\/17 &#8211; Down 4%)<\/strong>\u00a0Nothing has changed. Still good dividends and fundamentals. Solid holding.<\/p><footer itemscope itemtype=\"http:\/\/schema.org\/Person\"><cite><span itemprop=\"name\">Paul Macdonald<\/span><\/cite><\/footer><\/blockquote><\/div>\n<div class=\"perfect-pullquote vcard pullquote-align-full pullquote-border-placement-left\"><blockquote><p>Like the stability. They are one of the leaders in immunotherapy and other lines of business. \u00a0Core holding. Dividend yield is 3.1%. Market cap $165.8 billion.<em>\u00a0(Analysts\u2019 price target is $69.16)<\/em><\/p><footer itemscope itemtype=\"http:\/\/schema.org\/Person\"><cite><span itemprop=\"name\">Paul Macdonald<\/span><\/cite><\/footer><\/blockquote><\/div>\n<p>[nextpage title=&#8221;A stable old-school Pharma company&#8221;]<\/p>\n<h6><span class=\"ez-toc-section\" id=\"PFE-N\"><\/span>PFE-N<span class=\"ez-toc-section-end\"><\/span><\/h6>\n<h3><span class=\"ez-toc-section\" id=\"Pfizer_Inc\"><\/span>Pfizer Inc.<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><img loading=\"lazy\" decoding=\"async\" title=\"pfizer.png\" src=\"https:\/\/stockchase.com\/discover\/wp-content\/uploads\/2018\/07\/pfizer.png\" alt=\"Pfizer\" width=\"794\" height=\"498\" border=\"0\" \/>[adinserter block=&#8221;4&#8243;]<\/p>\n<!-- TradingView Widget BEGIN -->\r\n<div class=\"tradingview-widget-container\">\r\n  <div id=\"tradingview_1756ad\"><\/div>\r\n  <div class=\"tradingview-widget-copyright\"><a href=\"https:\/\/www.tradingview.com\/symbols\/NYSE-PFE\/\" rel=\"noopener\" target=\"_blank\"><span class=\"blue-text\">PFE chart<\/span><\/a> by TradingView<\/div>\r\n  <script type=\"text\/javascript\" src=\"https:\/\/s3.tradingview.com\/tv.js\"><\/script>\r\n  <script type=\"text\/javascript\">\r\n  new TradingView.widget(\r\n  {\r\n  \"autosize\": true,\r\n  \"symbol\": \"NYSE:PFE\",\r\n  \"interval\": \"D\",\r\n  \"timezone\": \"Etc\/UTC\",\r\n  \"theme\": \"Light\",\r\n  \"style\": \"3\",\r\n  \"locale\": \"en\",\r\n  \"toolbar_bg\": \"#f1f3f6\",\r\n  \"enable_publishing\": false,\r\n  \"hide_top_toolbar\": true,\r\n  \"allow_symbol_change\": true,\r\n  \"save_image\": false,\r\n  \"referral_id\": \"12055\",\r\n  \"container_id\": \"tradingview_1756ad\"\r\n}\r\n  );\r\n  <\/script>\r\n<\/div>\r\n<!-- TradingView Widget END -->\r\n\u00a0\n<p><a href=\"https:\/\/stockchase.com\/company\/view\/811\">Pfizer Inc.<\/a> was a Top Pick back in January, but stock experts still like the stock.<\/p>\n<div class=\"perfect-pullquote vcard pullquote-align-full pullquote-border-placement-left\"><blockquote><p><strong>(A Top Pick May 31\/17 Up 20%)<\/strong>\u00a0\u00a0A stable, old-school pharma company. \u00a0They can still spin out some businesses and they have a lot good projects in the pipeline. <\/p><footer itemscope itemtype=\"http:\/\/schema.org\/Person\"><cite><span itemprop=\"name\">Michael Simpson<\/span><\/cite><\/footer><\/blockquote><\/div>\n<div class=\"perfect-pullquote vcard pullquote-align-full pullquote-border-placement-left\"><blockquote cite=\"https:\/\/stockchase.com\/expert\/view\/1137\/\"><p>140 drugs that generate over $100 million in revenues. They have a good pipeline. Some interesting data on pain medication. Consistent revenue. Great valuation. There is no reason why this company shouldn\u2019t be trading at 14 times earnings and it is trading at 11.5x. he expects a multiple expansion.<\/p><footer itemscope itemtype=\"http:\/\/schema.org\/Person\"><cite><a href=\"https:\/\/stockchase.com\/expert\/view\/1137\/\" class=\"url\" target=\"_blank\" itemprop=\"url\"><span itemprop=\"name\">Paul Macdonald<\/span><\/a><\/cite><\/footer><\/blockquote><\/div>\n<div class=\"perfect-pullquote vcard pullquote-align-full pullquote-border-placement-left\"><blockquote><p><strong>(A Top Pick June 16\/17, Up 12% )<\/strong>\u00a0Likes pharma and owns a couple of them. The time to buy is when they are facing a patent clift, and their biggest drugs are coming off-patents and the company has to find new drugs or buy other promising companies. Pfizer was one of those when they bought Wyeth. They have a big consumer products division, which provides lots of cash flow, good earnings but not huge growth, which they put up for sell recently but couldn\u2019t really find a buyer. Still likes it longer term.<\/p><footer itemscope itemtype=\"http:\/\/schema.org\/Person\"><cite><span itemprop=\"name\">Norman Levine<\/span><\/cite><\/footer><\/blockquote><\/div>\n","protected":false},"excerpt":{"rendered":"<p>[adinserter block=&#8221;4&#8243;] 2018: Volatile year for drug manufacturers 2018 remains the volatile year for the drug manufacturers. The recent steep rise in US Pharma companies has pushed the overall Pharma index upwards. Upon May 11, 2018 announcement of\u00a0President Donald J. [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":985,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cwp_meta_box_check":"No","cwp_rev_product_name":"","cwp_rev_product_image":"","wppr_links":[],"cwp_rev_price":"","wppr_options":[],"wppr_pros":[],"wppr_cons":[],"footnotes":""},"categories":[17],"tags":[23,22,18,19,21,20],"class_list":["post-956","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lists","tag-chart","tag-expert-opinion","tag-pharma","tag-stocks","tag-trading","tag-trend-following"],"wppr_data":{"cwp_meta_box_check":"No"},"_links":{"self":[{"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/posts\/956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/comments?post=956"}],"version-history":[{"count":0,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/posts\/956\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/media\/985"}],"wp:attachment":[{"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/media?parent=956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/categories?post=956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stockchase.com\/discover\/wp-json\/wp\/v2\/tags?post=956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}